Diagnostic marker aids diagnosis for aggressive prostate cancer

The FOXA1 protein is a potentially highly sensitive diagnostic marker for small cell carcinoma of the prostate and possibly ...
Fred Hutch

Interrogating heterogeneous PSMA expression in advanced prostate cancer

The core foundation of precision medicine, and in turn, precision oncology, is a personalized approach to treatment that focuses on targeting specific molecular features that impact how cancer cells ...
Fred Hutch

Assessing HER2 expression in metastatic prostate and urothelial cancers

Distinguishing cancer cells from healthy cells is a central challenge in cancer treatment. Ideal therapies selectively kill cancer cells while leaving healthy cells healthy and able to perform their ...
ascopubs.org

Circulating tumor cell (CTC) expression patterns of cell surface targets in metastatic prostate cancer.

Evaluating associations between genomic classifier and digital pathology–based multi-modal AI biomarkers in oligometastatic castration-sensitive prostate cancer.
ascopubs.org

Loss of ANPEP expression may promote the development of aggressive prostate cancer.

Potential risk factors, course of disease, and clinical outcomes of neuroendocrine prostate cancer (NEPC): A retrospective analysis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting ...